Biosense Webster Inc (Biosense Webster), a subsidiary of Johnson & Johnson, is a medical device company that designs, manufactures and markets cardiac arrhythmias products. The company’s products include ablation catheters, diagnostic catheters and access, ultrasound catheters and 3D cardiac mapping. It also offers fibrillation, ventricular tachycardia, atrial flutter, simple arrhythmias and fluoro reduction solutions. Biosense Webster provides onsite training, offsite workshops, online training, EP training and professional and medical education services. The company offers training and online courses through its education centers in the US, Germany, Belgium, Sweden and Spain. Biosense Webster is headquartered in Diamond Bar, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Biosense Webster Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Biosense Webster Inc Company Overview
- Biosense Webster Inc Company Snapshot
- Biosense Webster Inc Pipeline Products and Ongoing Clinical Trials Overview
- Biosense Webster Inc - Pipeline Analysis Overview
- Biosense Webster Inc - Key Facts
- Biosense Webster Inc - Major Products and Services
- Biosense Webster Inc Pipeline Products by Development Stage
- Biosense Webster Inc Ongoing Clinical Trials by Trial Status
- Biosense Webster Inc Pipeline Products Overview
- 3D Ultrasound Next Generation Catheter
- 3D Ultrasound Next Generation Catheter Product Overview
- CARTO 3 EP Navigation System Software V9.0
- CARTO 3 EP Navigation System Software V9.0 Product Overview
- CARTO 4
- CARTO 4 Product Overview
- Heliostar
- Heliostar Product Overview
- Heliostar Clinical Trial
- Omnypulse Bi-Directional Catheter
- Omnypulse Bi-Directional Catheter Product Overview
- Omnypulse Bi-Directional Catheter Clinical Trial
- RF Needle Transseptal Sheath
- RF Needle Transseptal Sheath Product Overview
- Thermocool Smarttouch SF Dual Energy Catheter
- Thermocool Smarttouch SF Dual Energy Catheter Product Overview
- Thermocool Smarttouch SF Dual Energy Catheter Clinical Trial
- THERMOCOOL SMARTTOUCH SF-5D Catheter
- Product Status
- Biosense Webster Inc - Key Competitors
- Biosense Webster Inc - Key Employees
- Biosense Webster Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Biosense Webster Inc, Recent Developments
- Feb 28, 2025: Ablation Catheter Correction: Biosense Webster Updates Use Instructions for Varipulse due to High Rate of Stroke or Transient Ischemic Attack
- Feb 17, 2025: Johnson & Johnson to resume market release of Varipulse catheter in US
- Feb 14, 2025: Johnson & Johnson to Resume U.S. VARIPULSE Cases
- Jan 13, 2025: Johnson & Johnson MedTech’s Dual Energy Catheter gains CE mark approval
- Jan 08, 2025: Johnson & Johnson Statement on VARIPULSE U.S. External Evaluation
- Nov 21, 2024: Biosense Webster Receives PMA Approval For VARIPULSE Platform
- Nov 08, 2024: Johnson & Johnson MedTech’s VARIPULSE Platform Receives FDA Approval for AFib
- Nov 01, 2024: Johnson & Johnson MedTech concludes enrolment for OMNY-AF trial pilot phase
- Oct 24, 2024: Biosense Webster Receives FDA 510(k) Clearance for Webster Duo-Decapolar Diagnostic EP Catheter
- Oct 22, 2024: The Evolving Landscape of Atrial Fibrillation Ablation: Varipulse Launches in European Hospitals
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- Biosense Webster Inc Pipeline Products and Ongoing Clinical Trials Overview
- Biosense Webster Inc Pipeline Products by Equipment Type
- Biosense Webster Inc Pipeline Products by Indication
- Biosense Webster Inc Ongoing Clinical Trials by Trial Status
- Biosense Webster Inc, Key Facts
- Biosense Webster Inc, Major Products and Services
- Biosense Webster Inc Number of Pipeline Products by Development Stage
- Biosense Webster Inc Pipeline Products Summary by Development Stage
- Biosense Webster Inc Ongoing Clinical Trials by Trial Status
- Biosense Webster Inc Ongoing Clinical Trials Summary
- 3D Ultrasound Next Generation Catheter - Product Status
- 3D Ultrasound Next Generation Catheter - Product Description
- CARTO 3 EP Navigation System Software V9.0 - Product Status
- CARTO 3 EP Navigation System Software V9.0 - Product Description
- CARTO 4 - Product Status
- CARTO 4 - Product Description
- Heliostar - Product Status
- Heliostar - Product Description
- Heliostar - Implementation of the HELIOSTAR in Real-world Clinical Practice at a High-volume Center - Operator Learning Curve and Procedural Outcome Parameters
- Omnypulse Bi-Directional Catheter - Product Status
- Omnypulse Bi-Directional Catheter - Product Description
- Omnypulse Bi-Directional Catheter - Assessment of Safety and Effectiveness in Treatment Management of Paroxysmal Atrial Fibrillation with the BWI Pulsed Field Ablation System with OMNYPULSE Catheter
- Omnypulse Bi-Directional Catheter - Safety and Effectiveness Evaluation of the OMNYPULSE Catheter with the TRUPULSE Generator for Treatment of Paroxysmal Atrial Fibrillation (PAF)
- RF Needle Transseptal Sheath - Product Status
- RF Needle Transseptal Sheath - Product Description
- Thermocool Smarttouch SF Dual Energy Catheter - Product Status
- Thermocool Smarttouch SF Dual Energy Catheter - Product Description
- Thermocool Smarttouch SF Dual Energy Catheter - A Prospective Randomized Study for the Evaluation of the Impact of Point-by-Point Pulse Field Ablation on Autonomic Nervous System Modulation in Paroxysmal Atrial Fibrillation
- Thermocool Smarttouch SF Dual Energy Catheter - Safety and Effectiveness Evaluation of the THERMOCOOL SMARTTOUCH SF Catheter with the TRUPULSE Generator for Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation (PAF)
- Thermocool Smarttouch SF Dual Energy Catheter - Safety and Effectiveness Evaluation of the THERMOCOOL SMARTTOUCH SF Catheter With the TRUPULSE Generator for Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation (PAF)
- Thermocool Smarttouch SF Dual Energy Catheter - The Thermocool SmartTouch SF Catheter With the Trupulse Generator for Endocardial Ablation in Patients With Ventricular Tachycardia
- Product Status
- THERMOCOOL SMARTTOUCH SF-5D Catheter - Product Description
- Biosense Webster Inc, Key Employees
- Biosense Webster Inc, Subsidiaries
- Glossary
- Biosense Webster Inc Pipeline Products by Equipment Type
- Biosense Webster Inc Pipeline Products by Development Stage
- Biosense Webster Inc Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Cook Medical Inc
- Boston Scientific Corp
- Biomerica Inc
- DFine Inc
- Cortech Solutions Inc
